Chemoinformaics analysis of 4,5-Di-o-cafeoylquinic acid
| Molecular Weight | 516.455 | nRot | 7 |
| Heavy Atom Molecular Weight | 492.263 | nRig | 23 |
| Exact Molecular Weight | 516.127 | nRing | 3 |
| Solubility: LogS | -2.6 | nHRing | 0 |
| Solubility: LogP | 1.773 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 67.377 |
| nHD | 7 | BPOL | 30.153 |
| QED | 0.156 |
| Synth | 4.141 |
| Natural Product Likeliness | 1.642 |
| NR-PPAR-gamma | 0.943 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.22 |
| HIA | 0.901 |
| CACO-2 | -6.273 |
| MDCK | 0.00000876 |
| BBB | 0.107 |
| PPB | 0.98144 |
| VDSS | 0.325 |
| FU | 0.0199995 |
| CYP1A2-inh | 0.154 |
| CYP1A2-sub | 0.029 |
| CYP2c19-inh | 0.079 |
| CYP2c19-sub | 0.044 |
| CYP2c9-inh | 0.378 |
| CYP2c9-sub | 0.455 |
| CYP2d6-inh | 0.051 |
| CYP2d6-sub | 0.165 |
| CYP3a4-inh | 0.078 |
| CYP3a4-sub | 0.053 |
| CL | 5.195 |
| T12 | 0.953 |
| hERG | 0.025 |
| Ames | 0.029 |
| ROA | 0.077 |
| SkinSen | 0.94 |
| Carcinogencity | 0.127 |
| EI | 0.045 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.77 |
| Antiviral | Yes |
| Prediction | 0.784746 |